Knight Therapeutics

About:

Knight Therapeutics is a specialty pharmaceutical company focused on acquiring or in-licensing.

Top Investors: International Finance Corporation, Long Zone Holdings, 3487911 Canada Inc.

Description:

Knight Therapeutics is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the markets.

Total Funding Amount:

$529M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Westmount, Quebec, Canada

Founded Date:

1995-01-01

Contact Email:

info(AT)gud-knight.com

Founders:

Jonathan Ross Goodman

Number of Employees:

501-1000

Last Funding Date:

2022-12-23

IPO Status:

Public

Industries:

Biotechnology